Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse.

Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, Cornelisse LN, Farrell RJ, Goldschmidt HL, Howrigan DP, Hussain NK, Imig C, de Jong APH, Jung H, Kohansalnodehi M, Kramarz B, Lipstein N, Lovering RC, MacGillavry H, Mariano V, Mi H, Ninov M, Osumi-Sutherland D, Pielot R, Smalla KH, Tang H, Tashman K, Toonen RFG, Verpelli C, Reig-Viader R, Watanabe K, van Weering J, Achsel T, Ashrafi G, Asi N, Brown TC, De Camilli P, Feuermann M, Foulger RE, Gaudet P, Joglekar A, Kanellopoulos A, Malenka R, Nicoll RA, Pulido C, de Juan-Sanz J, Sheng M, Südhof TC, Tilgner HU, Bagni C, Bayés À, Biederer T, Brose N, Chua JJE, Dieterich DC, Gundelfinger ED, Hoogenraad C, Huganir RL, Jahn R, Kaeser PS, Kim E, Kreutz MR, McPherson PS, Neale BM, O'Connor V, Posthuma D, Ryan TA, Sala C, Feng G, Hyman SE, Thomas PD, Smit AB, Verhage M.

Neuron. 2019 Jul 17;103(2):217-234.e4. doi: 10.1016/j.neuron.2019.05.002. Epub 2019 Jun 3.

PMID:
31171447
2.

Predicting Polygenic Risk of Psychiatric Disorders.

Martin AR, Daly MJ, Robinson EB, Hyman SE, Neale BM.

Biol Psychiatry. 2019 Jul 15;86(2):97-109. doi: 10.1016/j.biopsych.2018.12.015. Epub 2018 Dec 28. Review.

PMID:
30737014
3.

The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience.

Ramos KM, Grady C, Greely HT, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE, Churchill JD, Gordon JA, Koroshetz WJ.

Neuron. 2019 Feb 6;101(3):394-398. doi: 10.1016/j.neuron.2019.01.024.

4.

New Evidence for Shared Risk Architecture of Mental Disorders.

Hyman SE.

JAMA Psychiatry. 2019 Mar 1;76(3):235-236. doi: 10.1001/jamapsychiatry.2018.4269. No abstract available.

PMID:
30649144
5.

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, Dua T, Poznyak V, Medina-Mora ME, Pike KM, Ayuso-Mateos JL, Kanba S, Keeley JW, Khoury B, Krasnov VN, Kulygina M, Lovell AM, de Jesus Mari J, Maruta T, Matsumoto C, Rebello TJ, Roberts MC, Robles R, Sharan P, Zhao M, Jablensky A, Udomratn P, Rahimi-Movaghar A, Rydelius PA, Bährer-Kohler S, Watts AD, Saxena S.

World Psychiatry. 2019 Feb;18(1):3-19. doi: 10.1002/wps.20611.

6.

Neuroethics Guiding Principles for the NIH BRAIN Initiative.

Greely HT, Grady C, Ramos KM, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE.

J Neurosci. 2018 Dec 12;38(50):10586-10588. doi: 10.1523/JNEUROSCI.2077-18.2018. No abstract available.

7.

The importance of true collaboration in efforts to increase diversity in genetic analyses.

Hyman SE.

Curr Biol. 2018 May 21;28(10):R598. doi: 10.1016/j.cub.2018.04.039.

8.

Publisher Correction: Whole genome sequencing in psychiatric disorders: the WGSPD consortium.

Sanders SJ, Neale BM, Huang H, Werling DM, An JY, Dong S, Abecasis G, Arguello PA, Blangero J, Boehnke M, Daly MJ, Eggan K, Geschwind DH, Glahn DC, Goldstein DB, Gur RE, Handsaker RE, McCarroll SA, Ophoff RA, Palotie A, Pato CN, Sabatti C, State MW, Willsey AJ, Hyman SE, Addington AM, Lehner T, Freimer NB; Whole Genome Sequencing for Psychiatric Disorders (WGSPD).

Nat Neurosci. 2018 Jul;21(7):1017. doi: 10.1038/s41593-018-0102-8.

PMID:
29549319
9.

Steven E. Hyman.

Hyman SE.

Curr Biol. 2018 Jan 8;28(1):R6-R8. doi: 10.1016/j.cub.2017.11.054. Epub 2018 Jan 8.

10.

The daunting polygenicity of mental illness: making a new map.

Hyman SE.

Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742). pii: 20170031. doi: 10.1098/rstb.2017.0031. Review.

11.

Whole genome sequencing in psychiatric disorders: the WGSPD consortium.

Sanders SJ, Neale BM, Huang H, Werling DM, An JY, Dong S; Whole Genome Sequencing for Psychiatric Disorders (WGSPD), Abecasis G, Arguello PA, Blangero J, Boehnke M, Daly MJ, Eggan K, Geschwind DH, Glahn DC, Goldstein DB, Gur RE, Handsaker RE, McCarroll SA, Ophoff RA, Palotie A, Pato CN, Sabatti C, State MW, Willsey AJ, Hyman SE, Addington AM, Lehner T, Freimer NB.

Nat Neurosci. 2017 Dec;20(12):1661-1668. doi: 10.1038/s41593-017-0017-9. Review. No abstract available. Erratum in: Nat Neurosci. 2018 Mar 16;:.

PMID:
29184211
12.

The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.

Kotov R, Krueger RF, Watson D, Achenbach TM, Althoff RR, Bagby RM, Brown TA, Carpenter WT, Caspi A, Clark LA, Eaton NR, Forbes MK, Forbush KT, Goldberg D, Hasin D, Hyman SE, Ivanova MY, Lynam DR, Markon K, Miller JD, Moffitt TE, Morey LC, Mullins-Sweatt SN, Ormel J, Patrick CJ, Regier DA, Rescorla L, Ruggero CJ, Samuel DB, Sellbom M, Simms LJ, Skodol AE, Slade T, South SC, Tackett JL, Waldman ID, Waszczuk MA, Widiger TA, Wright AGC, Zimmerman M.

J Abnorm Psychol. 2017 May;126(4):454-477. doi: 10.1037/abn0000258. Epub 2017 Mar 23. Review.

PMID:
28333488
13.

A Valuable New Direction in Ethical Analysis of Psychiatric Genetics.

Hyman SE.

Am J Bioeth. 2017 Apr;17(4):13-15. doi: 10.1080/15265161.2017.1285145. No abstract available.

PMID:
28328368
14.

A New Hope for Biological Insights Into Depression.

Hyman SE.

Biol Psychiatry. 2017 Feb 15;81(4):280-281. doi: 10.1016/j.biopsych.2016.12.001. No abstract available.

PMID:
28089024
15.

Back to basics: luring industry back into neuroscience.

Hyman SE.

Nat Neurosci. 2016 Oct 26;19(11):1383-1384. doi: 10.1038/nn.4429. No abstract available.

PMID:
27786185
16.

Research Into Brain Disorders as an Example of Targeted Science.

Hyman SE, Landis SC, Leshner AI.

JAMA. 2016 Oct 25;316(16):1673-1674. doi: 10.1001/jama.2016.12412. No abstract available.

PMID:
27668392
17.

Genetic research in autism spectrum disorders.

Robinson EB, Neale BM, Hyman SE.

Curr Opin Pediatr. 2015 Dec;27(6):685-91. doi: 10.1097/MOP.0000000000000278. Review.

18.

Enlisting hESCs to Interrogate Genetic Variants Associated with Neuropsychiatric Disorders.

Hyman SE.

Cell Stem Cell. 2015 Sep 3;17(3):253-4. doi: 10.1016/j.stem.2015.08.013.

19.

Protect researchers from harassment.

Hyman SE, Goldberg ME.

Science. 2015 Jun 12;348(6240):1216-7. doi: 10.1126/science.348.6240.1216-c. No abstract available.

PMID:
26068840
20.

The development of the ICD-11 Clinical Descriptions and Diagnostic Guidelines for Mental and Behavioural Disorders.

First MB, Reed GM, Hyman SE, Saxena S.

World Psychiatry. 2015 Feb;14(1):82-90. doi: 10.1002/wps.20189.

21.

Post-traumatic stress disorder.

Yehuda R, Hoge CW, McFarlane AC, Vermetten E, Lanius RA, Nievergelt CM, Hobfoll SE, Koenen KC, Neylan TC, Hyman SE.

Nat Rev Dis Primers. 2015 Oct 8;1:15057. doi: 10.1038/nrdp.2015.57. Review.

PMID:
27189040
22.

Improving and accelerating drug development for nervous system disorders.

Pankevich DE, Altevogt BM, Dunlop J, Gage FH, Hyman SE.

Neuron. 2014 Nov 5;84(3):546-53. doi: 10.1016/j.neuron.2014.10.007. Epub 2014 Nov 5. Review.

23.

The unconscionable gap between what we know and what we do.

Hyman SE.

Sci Transl Med. 2014 Sep 10;6(253):253cm9. doi: 10.1126/scitranslmed.3010312.

PMID:
25210058
24.

How far can mice carry autism research?

Hyman SE.

Cell. 2014 Jul 3;158(1):13-4. doi: 10.1016/j.cell.2014.06.032.

25.

Genome-scale neurogenetics: methodology and meaning.

McCarroll SA, Feng G, Hyman SE.

Nat Neurosci. 2014 Jun;17(6):756-63. doi: 10.1038/nn.3716. Epub 2014 May 27. Review.

26.

Perspective: Revealing molecular secrets.

Hyman SE.

Nature. 2014 Apr 3;508(7494):S20. doi: 10.1038/508S20a. No abstract available.

PMID:
24695333
27.

Time for new schizophrenia Rx.

Hyman SE.

Science. 2014 Mar 14;343(6176):1177. doi: 10.1126/science.1252603. No abstract available.

PMID:
24626901
28.

Revitalizing psychiatric therapeutics.

Hyman SE.

Neuropsychopharmacology. 2014 Jan;39(1):220-9. doi: 10.1038/npp.2013.181.

29.

Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology.

McCarroll SA, Hyman SE.

Neuron. 2013 Oct 30;80(3):578-87. doi: 10.1016/j.neuron.2013.10.046. Review.

30.

DSM-5 and RDoC: progress in psychiatry research?

Casey BJ, Craddock N, Cuthbert BN, Hyman SE, Lee FS, Ressler KJ.

Nat Rev Neurosci. 2013 Nov;14(11):810-4. doi: 10.1038/nrn3621. Review.

31.

Psychiatric drug development: diagnosing a crisis.

Hyman SE.

Cerebrum. 2013 Apr 2;2013:5. Print 2013 Mar. No abstract available.

32.

Revolution stalled.

Hyman SE.

Sci Transl Med. 2012 Oct 10;4(155):155cm11. doi: 10.1126/scitranslmed.3003142.

PMID:
23052291
33.

Might stimulant drugs support moral agency in ADHD children?

Hyman SE.

J Med Ethics. 2013 Jun;39(6):369-70; discussion 372-3. doi: 10.1136/medethics-2012-100846. Epub 2012 Sep 21.

34.

Target practice: HDAC inhibitors for schizophrenia.

Hyman SE.

Nat Neurosci. 2012 Sep;15(9):1180-1. doi: 10.1038/nn.3200. No abstract available.

PMID:
22929911
35.

Grand challenges in global mental health.

Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS; Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V, Sahakian BJ, Saxena S, Singer PA, Stein DJ.

Nature. 2011 Jul 6;475(7354):27-30. doi: 10.1038/475027a. No abstract available.

36.

Commentary: Repairing a plane while it is flying--reflections on Rutter (2011).

Hyman SE.

J Child Psychol Psychiatry. 2011 Jun;52(6):661-2; discussion 673-5. doi: 10.1111/j.1469-7610.2011.02386.x. Epub 2011 Mar 24. No abstract available.

PMID:
21434920
37.

Diagnosing the DSM: Diagnostic Classification Needs Fundamental Reform.

Hyman SE.

Cerebrum. 2011 Mar;2011:6. Epub 2011 Apr 26.

38.

Genome-sequencing anniversary. The meaning of the Human Genome Project for neuropsychiatric disorders.

Hyman SE.

Science. 2011 Feb 25;331(6020):1026. doi: 10.1126/science.1203544. No abstract available.

39.

Cognitive enhancement: promises and perils.

Hyman SE.

Neuron. 2011 Feb 24;69(4):595-8. doi: 10.1016/j.neuron.2011.02.012.

40.

Grouping diagnoses of mental disorders by their common risk factors.

Hyman SE.

Am J Psychiatry. 2011 Jan;168(1):1-3. doi: 10.1176/appi.ajp.2010.10111655. No abstract available.

PMID:
21205810
41.
42.

Animal models of neuropsychiatric disorders.

Nestler EJ, Hyman SE.

Nat Neurosci. 2010 Oct;13(10):1161-9. doi: 10.1038/nn.2647. Epub 2010 Sep 27. Review.

43.

A bone to pick with compulsive behavior.

Hyman SE.

Cell. 2010 May 28;141(5):752-4. doi: 10.1016/j.cell.2010.05.010.

44.

Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity?

Andrews G, Goldberg DP, Krueger RF, Carpenter WT, Hyman SE, Sachdev P, Pine DS.

Psychol Med. 2009 Dec;39(12):1993-2000. doi: 10.1017/S0033291709990250. Epub 2009 Oct 1. Review.

PMID:
19796425
45.

How adversity gets under the skin.

Hyman SE.

Nat Neurosci. 2009 Mar;12(3):241-3. doi: 10.1038/nn0309-241. No abstract available.

PMID:
19238182
46.

A glimmer of light for neuropsychiatric disorders.

Hyman SE.

Nature. 2008 Oct 16;455(7215):890-3. doi: 10.1038/nature07454.

PMID:
18923510
47.

How might cocaine interfere with brain development?

Hyman SE.

PLoS Med. 2008 Jun 10;5(6):e130. doi: 10.1371/journal.pmed.0050130. No abstract available.

48.

Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization.

Paletzki RF, Myakishev MV, Polesskaya O, Orosz A, Hyman SE, Vinson C.

Neuroscience. 2008 Apr 9;152(4):1040-53. doi: 10.1016/j.neuroscience.2008.01.045. Epub 2008 Feb 7.

49.

Cognition in schizophrenia.

Hyman SE, Ivleva E.

Am J Psychiatry. 2008 Mar;165(3):312. doi: 10.1176/appi.ajp.2008.08010114. No abstract available.

PMID:
18316429
50.

How mice cope with stressful social situations.

Hyman SE.

Cell. 2007 Oct 19;131(2):232-4.

Supplemental Content

Loading ...
Support Center